Monthly Archives: May 2018

Today’s Research Reports on Seven Generations Energy, Freehold Royalties, Africa Oil and Chinook Energy

NEW YORK, NY / ACCESSWIRE / May 31, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI has Initiated Coverage Today on:

Seven Generations Energy Ltd.
https://rdinvesting.com/news/?ticker=VII.TO

Freehold Royalties Ltd.
https://rdinvesting.com/news/?ticker=FRU.TO

Africa Oil Corp.
https://rdinvesting.com/news/?ticker=AOI.TO

Chinook Energy Inc.
https://rdinvesting.com/news/?ticker=CKE.TO

Seven Generations Energy’s stock edged 0.48% higher Wednesday, to close the day at $16.83. The stock recorded a trading volume of 763,711 shares, which was below its three months average volume of 1,152,023 shares. In the last year, Seven Generations Energy’s shares have traded in a range of 13.62 – 25.28. The share price has gained 23.57% from its 52 week low. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $17.43 is greater than its 200-day moving average of $16.89. Shares of Seven Generations Energy are trading at a Price to Earnings ratio of 16.63. Shares of Seven Generations Energy have fallen approximately 5.34 percent year-to-date.

Access RDI’s Seven Generations Energy Ltd. Research Report at:
https://rdinvesting.com/news/?ticker=VII.TO

On Wednesday, shares of Freehold Royalties recorded a trading volume of 536,762 shares, which was above the three months average volume of 261,814 shares. The stock ended the day 1.48% higher at 12.52. The stock is currently trading 23.71% below its 52-week high with a 52-week trading range of 11.71 – 16.41. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $13.20 is below its 200-day moving average of $13.49. Shares of Freehold Royalties are trading at a Price to Earnings ratio of 156.50. Shares of Freehold Royalties have fallen approximately 10.89 percent year-to-date.

Access RDI’s Freehold Royalties Ltd. Research Report at:
https://rdinvesting.com/news/?ticker=FRU.TO

Africa Oil’s stock jumped 7.20% Wednesday, to close the day at $1.34. The stock recorded a trading volume of 157,175 shares, which was above its three months average volume of 113,184 shares. In the last year, Africa Oil’s shares have traded in a range of 1.14 – 2.12. The share price has gained 17.54% from its 52 week low. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $1.23 is below its 200-day moving average of $1.37. Shares of Africa Oil have fallen approximately 5.63 percent year-to-date.

Access RDI’s Africa Oil Corp. Research Report at:
https://rdinvesting.com/news/?ticker=AOI.TO

On Wednesday, shares of Chinook Energy recorded a trading volume of 111,000 shares, which was above the three months average volume of 80,840 shares. The stock ended the day flat at 0.21. The share price has gained 23.53% from its 52-week low with a 52-week trading range of 0.17 – 0.37. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $0.20 is below its 200-day moving average of $0.22. Shares of Chinook Energy have fallen approximately 19.23 percent year-to-date.

Access RDI’s Chinook Energy Inc. Research Report at:
https://rdinvesting.com/news/?ticker=CKE.TO

Our Actionable Research on Seven Generations Energy Ltd. (TSX:VII.TO), Freehold Royalties Ltd. (TSX:FRU.TO), Africa Oil Corp. (TSX:AOI.TO) and Chinook Energy Inc. (TSX:CKE.TO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 501338

Today’s Research Reports on Amerigo Resources, Azarga Uranium, Great Panther Silver and First Quantum Minerals

NEW YORK, NY / ACCESSWIRE / May 31, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI has Initiated Coverage Today on:

Amerigo Resources Ltd.
https://rdinvesting.com/news/?ticker=ARG.TO

Azarga Uranium Corp.
https://rdinvesting.com/news/?ticker=AZZ.TO

Great Panther Silver Ltd.
https://rdinvesting.com/news/?ticker=GPR.TO

First Quantum Minerals Ltd.
https://rdinvesting.com/news/?ticker=FM.TO

Amerigo Resources’ stock had no change Wednesday, to close the day at $0.97. The stock recorded a trading volume of 106,839 shares, which was above its three months average volume of 77,857 shares. In the last year, Amerigo Resources’ shares have traded in a range of 0.49 – 1.35. The share price has gained 97.96% from its 52 week low. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $1.03 is below its 200-day moving average of $1.05. Shares of Amerigo Resources are trading at a Price to Earnings ratio of 24.25. Shares of Amerigo Resources have fallen approximately 11.82 percent year-to-date.

Access RDI’s Amerigo Resources Ltd. Research Report at:
https://rdinvesting.com/news/?ticker=ARG.TO

On Wednesday, shares of Azarga Uranium recorded a trading volume of 21,600 shares, which was below the three months average volume of 30,777 shares. The stock ended the day 1.89% lower at 0.26. The share price has gained 44.44% from its 52 week low with a 52 week trading range of 0.18 – 0.34. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $0.26 is greater than its 200-day moving average of $0.24. Shares of Azarga Uranium have gained approximately 23.81 percent year-to-date.

Access RDI’s Azarga Uranium Corp. Research Report at:
https://rdinvesting.com/news/?ticker=AZZ.TO

Great Panther Silver’s stock moved 1.83% lower Wednesday, to close the day at $1.61. The stock recorded a trading volume of 13,502 shares, which was below its three months average volume of 62,671 shares. In the last year, Great Panther Silver’s shares have traded in a range of 1.39 – 1.86. The share price has gained 15.83% from its 52 week low. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $1.58 is greater than its 200-day moving average of $1.56. Shares of the company are trading at a Price to Earnings ratio of 201.25. Shares of Great Panther Silver have fallen approximately 1.23 percent year-to-date.

Access RDI’s Great Panther Silver Ltd. Research Report at:
https://rdinvesting.com/news/?ticker=GPR.TO

On Wednesday, shares of First Quantum Minerals recorded a trading volume of 2,208,162 shares, which was below the three months average volume of 2,639,228 shares. The stock ended the day 4.10% higher at 19.79. The share price has gained 104.23% from its 52 week low with a 52 week trading range of 9.69 – 22.36. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $19.30 is greater than its 200-day moving average of $18.45. Shares of First Quantum Minerals have gained approximately 12.38 percent year-to-date.

Access RDI’s First Quantum Minerals Ltd. Research Report at:
https://rdinvesting.com/news/?ticker=FM.TO

Our Actionable Research on Amerigo Resources Ltd. (TSX:ARG.TO), Azarga Uranium Corp. (TSX:AZZ.TO), Great Panther Silver Ltd. (TSX:GPR.TO) and First Quantum Minerals Ltd. (TSX:FM.TO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 501339

Today’s Research Reports on Inspira Financial, Routemaster Capital, The Westaim and ECN Capital

NEW YORK, NY / ACCESSWIRE / May 31, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI has Initiated Coverage Today on:

Inspira Financial Inc.
https://rdinvesting.com/news/?ticker=LND.V

Routemaster Capital Inc.
https://rdinvesting.com/news/?ticker=RM.V

The Westaim Corporation
https://rdinvesting.com/news/?ticker=WED.V

ECN Capital Corp.
https://rdinvesting.com/news/?ticker=ECN.TO

Inspira Financial’s stock had no change Wednesday, to close the day at $0.165. The stock recorded a trading volume of 13,014 shares, which was below its three months average volume of 28,774 shares. In the last year, Inspira Financial’s shares have traded in a range of 0.16 – 0.26. The stock is currently trading 35.29% below its 52 week high. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $0.174 is below its 200-day moving average of $0.189. Shares of Inspira Financial have fallen approximately 26.67 percent year-to-date.

Access RDI’s Inspira Financial Inc. Research Report at:
https://rdinvesting.com/news/?ticker=LND.V

On Wednesday, shares of Routemaster Capital recorded a trading volume of 16,000 shares, which was below the three months average volume of 61,247 shares. The stock ended the day flat at 0.12. The share price has gained 50.00% from its 52 week low with a 52 week trading range of 0.08 – 0.46. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $0.21 is below its 200-day moving average of $0.27. Shares of the company are trading at a Price to Earnings ratio of 9.23. Shares of Routemaster Capital have fallen approximately 66.67 percent year-to-date.

Access RDI’s Routemaster Capital Inc. Research Report at:
https://rdinvesting.com/news/?ticker=RM.V

The Westaim’s stock had no change Wednesday, to close the day at $3.28. The stock recorded a trading volume of 35,011 shares, which was below its three months average volume of 182,314 shares. In the last year, The Westaim’s shares have traded in a range of 2.74 – 3.36. The share price has gained 19.71% from its 52 week low. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $3.13 is greater than its 200-day moving average of $3.03. Shares of The Westaim are trading at a Price to Earnings ratio of 48.96. Shares of The Westaim have gained approximately 5.47 percent year-to-date.

Access RDI’s The Westaim Corporation Research Report at:
https://rdinvesting.com/news/?ticker=WED.V

On Wednesday, shares of ECN Capital recorded a trading volume of 696,231 shares, which was below the three months average volume of 1,172,938 shares. The stock ended the day 0.27% lower at 3.65. The share price has gained 21.67% from its 52 week low with a 52 week trading range of 3.00 – 4.40. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $3.52 is below its 200-day moving average of $3.69. Shares of the company are trading at a Price to Earnings ratio of 17.72. Shares of ECN Capital have fallen approximately 7.12 percent year-to-date.

Access RDI’s ECN Capital Corp. Research Report at:
https://rdinvesting.com/news/?ticker=ECN.TO

Our Actionable Research on Inspira Financial Inc. (TSXV:LND.V), Routemaster Capital Inc. (TSXV:RM.V), The Westaim Corporation (TSXV:WED.V) and ECN Capital Corp. (TSX:ECN.TO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 501340

Today’s Research Reports on Stocks to Watch: Michael Kors and Movado Group

NEW YORK, NY / ACCESSWIRE / May 31, 2018 / Both Michael Kors and Movado Group released quarterly results that beat expectations but Michael Kors shares plummeted instead of seeing the gains that Movado did. Movado closed up 16.59% and even hit a new high after releasing its first quarter results. Michael Kors shares sunk over 11% as analysts chimed in on the company’s weak Jimmy Choo sales and other concerns.

RDI Initiates Coverage on:

Michael Kors Holdings Limited
https://www.rdinvesting.com/report/?ticker=KORS

Movado Group, Inc.
https://www.rdinvesting.com/report/?ticker=MOV

Michael Kors Holdings Limited shares closed down 11.45% yesterday on nearly 18.3 million shares traded. Despite the luxury clothing and accessory company posting fourth quarter results that beat expectations, traders were more concerned over guidance and weak Jimmy Choo sales. For the quarter, Michael Kors reported revenue of $1.18 billion. This was an increase from the $1.06 billion it posted in the year ago quarter and easily beat the $1.15 billion that analysts on average were expecting. Adjusted earnings of 63 cents per share also topped street’s expectation of 60 cents per share. Neil Saunders, the managing director of GlobalData Retail remarked, “While the headline growth number from Michael Kors looks strong, it comes with three caveats. First, it is flattered by the addition of Jimmy Choo sales; when these are stripped out, growth plummets to a lackluster 0.6%.” He also wrote, “On apparel, we find some of the collection items incredulously expensive – $495 for a varsity T-shirt, and $8,995 for a silk skirt puts them well beyond the scope of even reasonably affluent Americans. Michael Kors will argue that they are positioned as luxury items at the pinnacle of its range, however, in our opinion, the design and styling do not justify the price points.” Traders are probably disappointed with the full year earnings guidance range of $4.65 to $4.75 per share. Analysts are expecting EPS to be $4.74, which is at the higher end of the guidance.

Access RDI’s Michael Kors Holdings Limited Research Report at:
https://www.rdinvesting.com/report/?ticker=KORS

Movado Group, Inc. shares closed up 16.59% on Wednesday with a little over 1.1 million shares traded. The luxury watch company saw its shares hit a new high of $49.85 after the company reported strong first quarter results. For the period, Movado reported that net sales saw an increase of 28.1% YOY and hit $127.1 million. Adjusted earnings of $8.7 million, or 37 cents per share, was up from the 1 cent per share reported in the year ago period. Analysts had been looking for adjusted earnings per share of 11 cents on revenue of $109.5 million. CEO Efraim Grinberg said the quarter was a “strong start to the year,” and also said, “Our first quarter results reflect the team’s consistent ability to bring innovation to market that resonates with consumers around the world,” Grinberg added, “which was further enhanced by the execution of our strategic growth priorities.” Traders were also enthused to learn that the company increased its outlook for the full year. Guidance is now calling for sales in the range of $615 million to $625 million. Previously the company had projected $605 million to $615 million.

Access RDI’s Movado Group, Inc. Research Report at:
https://www.rdinvesting.com/report/?ticker=MOV

Our Actionable Research on Michael Kors Holdings Limited (NYSE: KORS) and Movado Group, Inc. (NYSE: MOV) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 501341

Toronto Exchanges Stock Review Brookfield Renewable Partners, TransAlta Renewables, Northland Power, and Algonquin Power and Utilities

LONDON, UK / ACCESSWIRE / May 31, 2018 / Active-Investors free stock reports for this morning include these Toronto Exchanges’ equities from the Utilities – Independent Power Producers industry: Brookfield Renewable Partners, TransAlta Renewables, Northland Power, and Algonquin Power & Utilities. Access our complimentary up-to-the-minute research reports by becoming an online member now:

www.active-investors.com/registration-sg

The S&P/TSX Composite Index progressed 126.05 points, or 0.79%, to close Wednesday’s trading session at 16,048.66. The TSX Venture Exchange shaved off 0.97 points, or 0.13%, to finish at 767.68.

Moreover, the Utilities index was down by 0.25%, closing at 225.01.

Today’s stocks of interest consist of: Brookfield Renewable Partners L.P. (TSX: BEP-UN), TransAlta Renewables Inc. (TSX: RNW), Northland Power Inc. (TSX: NPI), and Algonquin Power & Utilities Corporation (TSX: AQN). Click the link below to view a sample of the free research report that will be available to you as a member of Active-Investors:

www.active-investors.com/registration-sg

Brookfield Renewable Partners L.P.

Hamilton, Bermuda-based Brookfield Renewable Partners L.P.’s stock lost 2.76%, to finish Wednesday’s session at $40.23 with a total volume of 84,015 shares traded. Over the last month and the previous three months, Brookfield Renewable Partners’ shares have advanced 3.18% and 3.29%, respectively. Shares of the Company, which owns a portfolio of renewable power generating facilities in the North America, Colombia, Brazil, Europe, and internationally, are trading above its 50-day moving average. Brookfield Renewable Partners’ 200-day moving average of $40.86 is above its 50-day moving average of $39.57. View the research report on BEP-UN.TO at:

www.active-investors.com/registration-sg/?symbol=BEP.UN

TransAlta Renewables Inc.

On Wednesday, shares in Calgary, Canada headquartered TransAlta Renewables Inc. recorded a trading volume of 249,847 shares, which was above their three months average volume of 194,383 shares. The stock ended the day 0.81% higher at $12.48. TransAlta Renewables’ stock has gained 8.90% in the last month and 6.58% in the previous three months. The Company’s shares are trading above its 50-day and 200-day moving averages. The company stock’s 200-day moving average of $12.31 is above its 50-day moving average of $11.77. Shares of TransAlta Renewables, which develops, owns, and operates renewable power generation facilities, are trading at a PE ratio of 62.71. Get the free report on RNW.TO at:

www.active-investors.com/registration-sg/?symbol=RNW

Northland Power Inc.

Toronto, Canada headquartered Northland Power Inc.’s stock closed the day 0.29% lower at $24.15. The stock recorded a trading volume of 165,319 shares. Northland Power’s shares have gained 4.32% in the last month, 10.53% in the past three months, and 3.12% in the previous year. The Company’s shares are trading above their 50-day and 200-day moving averages. Moreover, the stock’s 50-day moving average of $23.50 is greater than its 200-day moving average of $23.06. Shares of the Company, which develops, builds, owns, and operates green power projects primarily in Canada and Europe, are trading at a PE ratio of 20.75. Access the most recent report coverage on NPI.TO at:

www.active-investors.com/registration-sg/?symbol=NPI

Algonquin Power & Utilities Corp.

On Wednesday, shares in Oakville, Canada headquartered Algonquin Power & Utilities Corp. ended the session 0.55% lower at $12.77 with a total volume of 722,895 shares traded. Algonquin Power & Utilities’ shares have advanced 2.16% in the last month. The stock is trading above its 50-day moving average. Furthermore, the stock’s 200-day moving average of $13.17 is greater than its 50-day moving average of $12.57. Shares of the Company, which through its subsidiaries, owns and operates a portfolio of regulated and non-regulated generation, distribution, and transmission utility assets in Canada and the US, are trading at a PE ratio of 190.60. Today’s complimentary report on AQN.TO can be accessed at:

www.active-investors.com/registration-sg/?symbol=AQN

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 501354

Long Island Capital Alliance to Hold Healthcare Capital Forum on June 8, 2018

Keynote Speaker: Eric Feinstein, Northwell Ventures Investment Director & Interim CEO of Clarapath

MELVILLE, NY / ACCESSWIRE / May 31, 2018 / The Long Island Capital Alliance (”LICA”), Long Island’s leading non-profit capital formation and business development organization, today announced the presenting companies and investor panelists for its Healthcare Capital Forum to be held on Friday, June 8, 2018. The capital forum will feature presentations by companies which have connections to the Long Island region and are building business around dynamic and emerging healthcare innovations.

Six companies in the healthcare sector will present their business plans to an audience that will include venture capital firms, investment banks, private equity firms, and angel and high net worth investors. Each of the companies selected by LICA for presentation at the capital forum possesses innovative intellectual properties and processes to innovatively address issues facing the life sciences sector for improvements in treatment, efficacy and profitability. A panel of investment professionals will review the presentations, offer their insights on the presenters’ commercial viability and prospects for market success and provide expert commentary on investment conditions in the broader healthcare sector.

Healthcare Capital Forum on June 8, 2018 – Participants

Key Note Speaker

Eric Feinstein, Northwell Ventures Investment Director & Interim CEO of Clarapath, will serve as guest speaker and panelist at LICA’s Healthcare Capital Forum. As an investment of Northwell Ventures, Clarapath is transforming anatomic pathology through its holistic approach to high-throughput slide production, imaging and analysis. From semi-automated, precision sectioning technology to world-class imaging and analysis expertise, Clarapath represents the future of digital pathology. The company’s next-generation laboratory at the NY Genome Center together with its large-scale image repository and analysis platform are designed to handle the entire ”tissue to bits” pipeline for special research projects as well as larger-scale clinical needs.

Presenting Companies

My PA box: Market leader in researching, organizing and applying to Physician Assistant Programs around the world. Based in Levittown, NY

SeeThru: A blockchain ecosystem for healthcare payments, price transparency, and personal medical records. Based in NYC and Brooklyn, NY

Soundmind: Provide senior facilities residents and staff with instant access to information and to the outside world using voice-enabled A.I. devices. Based in Brooklyn, NY.

The Clinician Exchange: Clinician-marketplace platform for on-demand clinical education, e-learning, & virtual advisory services. Based in Pine Brook, NJ.

Theryon: On-demand physical therapy via mobile app and website, for treatment within hours in the patient’s home or office. Based in Valley Stream, NY.

Walk-in Dermatology: Eliminate the wait for ”convenient care” to patients through the use of technology & walk-in scheduling. Based in Jericho, NY.

Panel of Investors:

The following investment/industry professionals will participate in the investor panel at the Technology Capital Forum:

Eric Feinstein: Mr. Feinstein is Investment Director of Northwell Ventures, the corporate venture capital arm of Northwell Health (formerly North Shore-LIJ Health), and is Interim CEO of Clarapath, an investment of Northwell Ventures. He has a wealth of experiences in the venture and private equity arenas, having made investments into and serving on the boards of several later-stage medical device and healthcare service businesses. Earlier, he served in an operational capacity as the interim CEO for Healthflix, a healthcare IT start-up focused on transitions of care and patient engagement, and was a Director of the Northeast Transaction Advisory and M&A group at RGP. Prior to that, he was a Principal at BSV Consulting Group, a boutique venture capital consulting firm focused on driving top-line revenue growth and performing transaction due-diligence. Eric spent six years evaluating and structuring new investment opportunities at Ampersand Capital Partners and Landmark Partners. He holds a degree in Economics (with a concentration in Behavioral Economics) from Trinity College and has an MBA from Cornell University.

Neil Cohen: Mr. Cohen is the Founder/Chairman and served as President of Cohen & Company, LLC (”C&C”), the predecessor to Emerald Development Managers LP, an early stage growth equity investment firm. Mr. Cohen is also a co-founder, co-CEO, and Member of the Executive Committee of American Rock Salt Company LLC since its formation in 1996. From 1992 to 1994, he was Executive VP, CFO, and a board member of AmBase Corporation, a publicly held financial services company during a turnaround. From 1986 to 1992, Mr. Cohen was an investment banker at Dillon, Read & Co. Inc. specializing in M&A, leveraged finance and restructuring. Mr. Cohen holds an MS in Management from the MIT-Sloan School of Management and a Bachelors of Engineering Sciences in Mathematical Sciences from The Johns Hopkins University. He also serves on the board or advisory committee of a number of charities and schools.

Louis F. Romo: Mr. Romo is the founder and CEO of PurpleSun, Inc., a new health and light technology company. Distinctions received for his work include a 2011 grand prize from the New York State Business Plan competition, recognized within the 2011 GEW’s TOP 50 Most Promising Startups Globally from the Kauffman Foundation, and multiple invitations to the White House. He holds both bachelors of science and a master’s of science degree in biomedical engineering from Syracuse University.

LICA is hosting the Healthcare Capital Forum on Friday, June 8, 2018 from 8:00 a.m. to 11:00 a.m. at 68 South Service Road, Melville, NY, 11747. The capital forum provides an opportunity to meet capital providers, entrepreneurs, industry executives and businesses seeking capital, as well as to hear a panel of industry experts discuss financing alternatives for emerging healthcare companies. Investors receive complimentary admission.

Save the Dates – Other LICA Events

Capital Forums

September 14, 2018 Technology Capital Forum
December 7, 2018

About Long Island Capital Alliance

Since 1984, the Long Island Capital Alliance (www.licapital.org), formerly known as Long Island Venture Group, has been promoting business growth on Long Island. LICA seeks to create a productive and business-friendly environment that will afford area businesses access to the resources necessary to compete successfully in today’s markets. LICA serves as a focal point for the exchange of ideas among new and existing business enterprises, successful entrepreneurs, investors, and service providers. Through quarterly capital forums and special meetings, LICA brings together members of the region’s business community, and has been recognized as the place to turn to when small businesses need equity, debt, or other financing, or for investors to find an attractive investment opportunity.

LICA’s mission is to encourage economic development on Long Island by facilitating capital formation for a broad range of companies in various industries, from early stage to mature, middle market, closely held and publicly-traded businesses. LICA accomplishes this primarily through education, networking, quarterly capital forums, periodic special educational meetings, and alliances with other regional organizations. LICA brings together members of the region’s business community and serves as the finance arm for significant local business and organizations.

For more information on LICA and its next event, please contact LICA today or register online at www.licapital.org.

Contact:

Jordan Darrow
Darrow Associates, Inc.
jdarrow@darrowir.com

SOURCE: The Long Island Capital Alliance

ReleaseID: 501272

AnalytixInsight to Present at the 8th Annual LD Micro Invitational

LOS ANGELES, CA / ACCESSWIRE / May 31, 2018 / Artificial Intelligence company AnalytixInsight Inc. (”AnalytixInsight,” or the ”Company”) (TSX-V: ALY; OTCQB: ATIXF) today announced that it will be presenting at the 8th annual LD Micro Invitational on Monday, June 4th at 3:30 PM PST. Scott Urquhart, VP Corporate Development of AnalytixInsight will be giving the presentation and meeting with investors.

”The event is slated to be our largest Invitational to date,” stated Chris Lahiji, President of LD Micro. ”When the fires caused the cancellation of our Main Event back in December, we vowed to come back even stronger. This event showcases our firm’s ability to attract the most unique and exciting names in micro-cap.”

The conference will be held at the Luxe Sunset Bel Air Hotel, will feature 230 companies in the small-cap / micro-cap space, and will be attended by over 1,000 individuals.

View AnalytixInsight’s profile here: https://www.ldmicro.com/profile/ALY.V.

Profiles powered by LD Micro – News Compliments of ACCESSWIRE.

About AnalytixInsight Inc.

AnalytixInsight’s (AnalytixInsight.com) artificial intelligence platform transforms data into knowledge. AnalytixInsight’s online portal CapitalCube (capitalcube.com) algorithmically analyzes market price data and regulatory filings to create insightful, actionable narratives and research on approximately 50,000 global companies and ETFs, providing high-quality financial research and content for investors, information providers, finance portals and media. AnalytixInsight holds a 49% interest in Marketwall, a mobile platform for banking and stock trading (marketwallcorporate.com). AnalytixInsight owns Euclides Technologies Inc. (euclidestech.com), a workflow analytics systems integrator.

AnalytixInsight is a 2018 Venture 50TMcompany (tsx.com/venture50).

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. The firm hosts several influential conferences annually (Invitational, Summit, and Main Event).

In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and micro-cap universe.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

Contact:

Name: Scott Urquhart
VP Corporate Development
Tel: (416) 522-3975
Scott.Urquhart@AnalytixInsight.com

SOURCE: AnalytixInsight Inc.

ReleaseID: 501275

Modern Mobility Aids, Inc. Terminates LOI with 2539296 Ontario Limited

TORONTO, ON / ACCESSWIRE / May 31, 2018 / Modern Mobility Aids, Inc. (OTC PINK: MDRM) (the ”Company”), announced today that the Company and 2539296 Ontario Limited mutually agreed to terminate the Letter of Intent between them dated October 12, 2017.

”MDRM will renew and strengthen it’s commitment to the company’s core business plan to develop medical cannabis related businesses in Canada and globally and we are reviewing opportunities in the continuously developing Cannabis industry ”stated Tito Dimarco, CEO.

About Modern Mobility Aids, Inc.

Modern Mobility Aids, Inc. is a development stage company that focuses on the health and wellness bio medical industry including production of medical marijuana. The company was founded on December 19, 2007 and is headquartered in Toronto, Canada.

For more information please contact:

Tito DiMarco, President, Treasurer and Secretary
Email: tdimarco@mdrminc.com
Tel: 416-890-0482

Safe Harbor

This news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the ”Act”). In particular, when used in the preceding of discussion, the words ”excited,” ”plan,” ”believe,” ”intends,” ”expects,” ”focused on” and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. There are no guarantees or assurances that any initiatives or negotiations will result in what the company had originally intended. Any investment made into Modern Mobility Aids, Inc., would be classified as speculative and risky. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the company’s products and technologies, competitive factors, the ability to successfully complete additional or adequate financing, government approvals or changes to proposed laws and other risks and uncertainties further stated in the company’s financial reports and filings.

SOURCE: Modern Mobility Aids, Inc.

ReleaseID: 501300

Emerald Health Pharmaceuticals Appoints Dr. Alain Rolland as Executive Vice President & Chief Development Officer

SAN DIEGO, CA / ACCESSWIRE / May 31, 2018 / Emerald Health Pharmaceuticals Inc. (EHP), which is developing medicines based on cannabinoid science, has appointed Alain Rolland, Pharm.D., Ph.D., as Executive Vice President and Chief Development Officer. Dr. Rolland brings over 30 years of international leadership experience in pharmaceutical and biotech companies. He has focused on the discovery and development of biologics and small molecules in a variety of therapeutic areas including immuno-oncology, cardiovascular and hematological disorders, dermatology, and infectious disease vaccines.

“We are pleased to have Dr. Rolland join our executive leadership team,” said Jim DeMesa, M.D., Chief Executive Officer of EHP. “We believe Alain’s leadership and track record of success will be essential as we continue to advance our development efforts to bring forward truly differentiated products based on cannabinoid science and prepare them to enter the clinic later this year.”

Prior to joining EHP, Dr. Rolland was a co-founder and served as CEO, President and Director of CHIME BioTherapeutics, Executive Vice President and Chief Scientific Officer at HUYA Bioscience International, Executive Vice President, Product Development at Vical, and Senior Vice President, Preclinical R&D, Head of The Woodlands Center of Valentis.

Dr. Rolland has published over 90 scientific articles and book chapters, and is editor of three scientific books. He is a member of several scientific societies, the founding Editor-in-Chief of Current Pharmaceutical Biotechnology, and an editorial board member of several journals. He is also the recipient of the Fellowship Award from the American Association of Pharmaceutical Scientists. Dr. Rolland earned his doctorate degree in Pharmacy (Pharm.D.) and in Pharmaceutical Sciences (Ph.D.) from Rennes University, France.

About Emerald Health Pharmaceuticals Inc.

Emerald Health Pharmaceuticals is developing product candidates derived from cannabinoids for the treatment of CNS, autoimmune, and other diseases. The company has two families of new chemical entities, based on cannabidiol, CBD, and cannabigerol, CBG, that it has modified through rational drug design to affect validated receptors pertinent to targeted diseases. Its first drug candidate, EHP-101, is focused on treating multiple sclerosis and scleroderma. Its second, EHP-102, is focused on treating Huntington’s disease and Parkinson’s disease. The company is advancing preclinical development with the intent to launch a Phase 1 clinical study in 2018. For more information, visit www.emeraldpharma.life or contact: info@emeraldpharma.life.

SOURCE: Emerald Health Pharmaceuticals Inc.

ReleaseID: 501302

Free Research Report as MetLife’s Q1 Bottom-Line Rose 13% Y-o-Y; Outshone Forecasts

Stock Monitor: National Western Life Group Post Earnings Reporting

LONDON, UK / ACCESSWIRE / May 31, 2018 / If you want access to our free earnings report on MetLife, Inc. (NYSE: MET), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=MET. The Company released its financial results on May 02, 2018, for the first quarter of the fiscal year 2018 (Q1 FY18). The New York-based Company’s adjusted earnings per share (EPS) rose 13% y-o-y; outperforming market consensus estimates. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for National Western Life Group, Inc. (NASDAQ: NWLI), which also belongs to the Financial sector as the Company MetLife. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=NWLI

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, MetLife most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=MET

Earnings Highlights and Summary

During Q1 FY18, MetLife reported total revenues of $14.81 billion versus $14.96 billion in the previous year’s same quarter. The Company’s adjusted revenues came in at $15.15 billion in the reported quarter, up 1% from the $15.05 billion recorded at the end of Q1 FY17. Wall Street had expected the Company to report adjusted revenues of $15.51 billion for the reported quarter. Furthermore, the Company’s adjusted premiums, fees, and other revenues were $10.93 billion in Q1 FY18 compared to $10.88 billion in Q1 FY17.

The insurance corporation reported a net income available to common shareholders of $1.25 billion, or $1.19 per share, in Q1 FY18 compared to $867 million, or $0.79 per share, in Q1 FY17. The Company’s adjusted earnings grew to $1.42 billion, or $1.36 per share, during Q1 FY18 from $1.32 billion, or $1.20 per share, in Q1 FY17. Moreover, market analysts had expected the Company to report adjusted EPS of $1.17.

Adjusted Metrics

The Company reported a return on equity (ROE) of 9.0% in Q1 FY18 compared to 5.3% in Q1 FY17. MetLife’s adjusted ROE, excluding AOCI other than FCTA, was 11.2% in the reported quarter compared to 6.3% in Q1 FY17. The Company’s adjusted tangible ROE was 14.4% in Q1 FY18 versus 7.8% in Q1 FY17. Furthermore, the Company’s book value per tangible common stockholders’ equity stood at $33.80 as on March 31, 2018, compared to $41.88 as on March 31, 2017.

Segment Performance

US – The segment’s total adjusted revenues increased to $7.34 billion in Q1 FY18 from $7.27 billion in Q1 FY17. The segment’s total premiums revenues also grew to $5.22 billion in Q1 FY18 from $5.19 billion in the last year’s comparable quarter. Furthermore, the segment’s adjusted earnings rose 31% to $653 million y-o-y in Q1 FY18.

Asia – For Q1 FY18, the segment’s adjusted revenues were $2.95 billion compared to $2.79 billion in the prior year’s corresponding quarter. The segment’s premiums revenues were $1.75 billion in Q1 FY18 compared to $1.71 billion in Q1 FY17. Moreover, the segment’s adjusted earnings increased 11% to $327 million y-o-y in Q1 FY18.

Latin America – MetLife’s Latin America segment generated adjusted revenues of $1.27 billion in Q1 FY18 compared to $1.22 billion in Q1 FY17. The segment’s total premiums revenues increased to $699 million during Q1 FY18 from $647 million in Q1 FY17. However, the segment’s adjusted earnings fell 2% to stand at $140 million y-o-y in Q1 FY18.

Europe, Middle-East, and Africa (EMEA) – During Q1 FY18, the segment’s adjusted revenues stood at $754 million compared to $688 million in Q1 FY17. The segment’s total premiums were $551 million in Q1 FY18 versus $502 million in Q1 FY17. Meanwhile, the segment’s adjusted earnings rose 8% to $81 million y-o-y in Q1 FY18.

MetLife Holdings – For Q1 FY18, the segment reported adjusted revenues of $2.68 billion compared to $2.96 billion in the year ago same quarter. The segment’s premiums revenues stood at $950 million in Q1 FY18 versus $1.06 billion in Q1 FY17. Furthermore, the segment’s adjusted earnings came in at $425 million in Q1 FY18, up from $387 million in Q1 FY17.

Corporate & Other – The segment’s adjusted revenues were $153 million in Q1 FY18, which came in below the $137 million reported in the year ago comparable quarter. The segment posted an adjusted loss of $197 million in the reported quarter, up from an adjusted loss of $70 million in Q1 FY17.

Dividend and Share Buyback

In a separate press release on April 24, 2018, MetLife’s Board of Directors declared a 5% hike in the second quarter FY18 common stock dividend to $0.42 per share. The dividend is payable on June 13, 2018, to shareholders of record as of May 07, 2018.

On May 22, 2018, the Company’s Board of Directors approved a new $1.5 billion authorization for the Company to repurchase its common stock. MetLife still has $370 million remaining under its 2017 share repurchase authorization of $2 billion.

Stock Performance Snapshot

May 30, 2018 – At Wednesday’s closing bell, MetLife’s stock rose 2.41%, ending the trading session at $46.25.

Volume traded for the day: 6.50 million shares, which was above the 3-month average volume of 5.48 million shares.

Stock performance in the previous three-month period – up 0.13%; and past twelve-month period – up 2.37%

After yesterday’s close, MetLife’s market cap was at $47.34 billion.

Price to Earnings (P/E) ratio was at 9.95.

The stock has a dividend yield of 3.46%.

The stock is part of the Financial sector, categorized under the Life Insurance industry. This sector was up 1.6% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 501329